Highlights
KLSE: APEX (5088)       APEX EQUITY HOLDINGS BHD MAIN : Finance
Last Price Today's Change   Day's Range   Trading Volume
0.88   0.00 (0.00%)  0.00 - 0.00  0
Trade this stock with up to 3 x trading limit. Find out more.

Financials


Market Cap: 188 Million

Market Cap 188 Million
NOSH 214 Million

Latest Audited Result:  31-Dec-2020

Latest Audited Result: 31-Dec-2020
Announcement Date 31-May-2021
Next Audited Result: 31-Dec-2021
Est. Ann. Date: 31-May-2022
Est. Ann. Due Date: 29-Jun-2022

Latest Quarter:  30-Jun-2021 [#2]

Latest Quarter: 30-Jun-2021 [#2]
Announcement Date 20-Aug-2021
Next Quarter: 30-Sep-2021
Est. Ann. Date: 12-Nov-2021
Est. Ann. Due Date: 29-Nov-2021
QoQ | YoY   16.99%  |    32.40%

Annual (Unaudited) ( EPS: 8.06, P/E: 10.92 )

Revenue | NP to SH 57,154  |  17,213
RPS | P/RPS 26.76 Cent  |  3.29
EPS | P/E | EY 8.06 Cent  |  10.92  |  9.16%
DPS | DY | Payout % 0.00 Cent  |  0.00%  |  - %
NAPS | P/NAPS 1.50  |  0.59
YoY   186.45%
NP Margin | ROE 30.12%  |  5.38%
F.Y. | Ann. Date 31-Dec-2020  |  25-Feb-2021

T4Q Result ( EPS: 10.10, P/E: 8.72 )

Revenue | NP to SH 64,769  |  21,562
RPS | P/RPS 30.33 Cent  |  2.90
EPS | P/E | EY 10.10 Cent  |  8.72  |  11.47%
DPS | DY | Payout % 1.90 Cent  |  2.16%  |  18.80%
NAPS | P/NAPS 1.54  |  0.57
QoQ | YoY   7.20%  |    140.49%
NP Margin | ROE 33.29%  |  6.57%
F.Y. | Ann. Date 30-Jun-2021  |  20-Aug-2021

Annualized Result ( EPS: 10.28, P/E: 8.56 )

Revenue | NP to SH 60,002  |  21,964
RPS | P/RPS 28.10 Cent  |  3.13
EPS | P/E | EY 10.28 Cent  |  8.56  |  11.69%
DPS | DY | Payout % -
NAPS | P/NAPS -
QoQ | YoY   8.50%  |    65.57%
NP Margin | ROE 36.61%  |  6.69%
F.Y. | Ann. Date 30-Jun-2021  |  20-Aug-2021



Business Performance

Business Performance (By Quarter)

Trailing 4 Quarters Trailing 8 Quarters
Available Quarters 4 Quarters 8 Quarters
Continuous Quarters Of Revenue Growth 0 / 4 0.00% 0 / 8 0.00%
Total Positive Profit Years 4 / 4 100.00% 8 / 8 100.00%
Continuous Quarters Of Positive Profit 4 / 4 100.00% 8 / 8 100.00%
Continuous Quarters Of Profit Growth 2 / 4 50.00% 2 / 8 25.00%
Continuous Quarters Of Adjusted EPS Growth 2 / 4 50.00% 2 / 8 25.00%
Total Dividend Years 2 / 4 50.00% 2 / 8 25.00%
Continuous Quarters Of Dividend 2 / 4 50.00% 2 / 8 25.00%
Continuous Quarters Of Dividend Growth 0 / 4 0.00% 0 / 8 0.00%
Continuous Quarters Of Adjusted Dps Growth 0 / 4 0.00% 0 / 8 0.00%
Average ROE 1.68% 1.21%
Average Net Profit Margin 33.74% 27.59%

Business Performance (By Year)

Last 5 Financial Years Last 10 Financial Years
Available Years 5 Years 10 Years
Continuous Years Of Revenue Growth 1 / 5 20.00% 1 / 10 10.00%
Total Positive Profit Years 5 / 5 100.00% 10 / 10 100.00%
Continuous Years Of Positive Profit 5 / 5 100.00% 10 / 10 100.00%
Continuous Years Of Profit Growth 1 / 5 20.00% 1 / 10 10.00%
Continuous Years Of Adjusted EPS Growth 1 / 5 20.00% 1 / 10 10.00%
Total Dividend Years 3 / 5 60.00% 8 / 10 80.00%
Continuous Years Of Dividend 0 / 5 0.00% 0 / 10 0.00%
Continuous Years Of Dividend Growth 0 / 5 0.00% 0 / 10 0.00%
Continuous Years Of Adjusted Dps Growth 0 / 5 0.00% 0 / 10 0.00%
Average ROE 3.73% 6.01%
Average Net Profit Margin 25.70% 33.67%

Key Result

Key Result

T4Q Annualized Annual (Unaudited) Last 10 FY Average Last 5 FY Average
Revenue 64,769 60,002 57,154 49,747 42,509
NP to SH 21,562 21,964 17,213 17,308 11,192
Dividend 4,052 8,105 - 11,964 3,647
Adjusted EPS 10.10 10.28 8.06 8.10 5.24
Adjusted DPS 1.90 3.80 0.00 5.60 1.71

NP to SH = Net Profit Attributable to Shareholder, EPS = Earning Per Share, DPS = Dividend Per Share

All figures in '000 unless specified.

EPS & DPS's figures in Cent.


Growth

Growth (By Quarter)

LQ QoQ LQ YoY CQ YoY LQ vs Average of T4Q LQ vs Average of T8Q
Revenue -17.78% 6.48% 34.02% -16.40% 4.50%
NP to Owner 16.99% 32.40% 65.57% 9.84% 55.16%
Dividend 0.00% 0.00% 0.00% 100.00% 300.00%
Adj. EPS 16.99% 32.40% 65.57% 9.84% 55.16%
Adj. DPS 0.00% 0.00% 0.00% 100.00% 300.00%

LQ = Latest Quarter, CQ = Cumulative Quarter, T4Q = Trailing 4 Quarters, T8Q = Trailing 8 Quarters, QoQ = Quarter on Quarter, YoY = Year on Year

Growth (By Year)

T4Q vs LFY T4Q vs AL5FY T4Q vs AL10FY AQR vs LFY AQR vs AL5FY AQR vs AL10FY LFY YoY LFY vs AL5FY LFY vs AL10FY
Revenue 13.32% 52.36% 30.20% 4.98% 41.15% 20.61% 68.11% 34.45% 14.89%
NP to Owner 25.27% 92.65% 24.57% 27.60% 96.24% 26.90% 186.45% 53.79% -0.55%
Dividend 0.00% 11.11% -66.13% - % - % - % 0.00% 0.00% 0.00%
Adj. EPS 25.27% 92.65% 24.57% 27.60% 96.24% 26.90% 186.45% 53.79% -0.55%
Adj. DPS 0.00% 11.11% -66.13% - % - % - % 0.00% 0.00% 0.00%

T4Q = Trailing 4 Quarters, T8Q = Trailing 8 Quarters, AL5FY = Average of Last 5 Financial Years, AL10FY = Average of Last 10 Financial Years, LFY = Latest Financial Year AQR = Annualized Quarter Result, YoY = Year on Year

Analyze this stock with MQ Trader system
  4 people like this.
 
SyedIbrahim Buy up and reap profit 2.50
10/12/2015 9:25 PM
SyedIbrahim It's time to go in buy buy buy ....
21/01/2016 9:54 PM
leroy Any news?
12/08/2016 4:26 PM
fanchong no news?
20/09/2016 8:03 PM
ACE9696 ape cerita ? matilah matilah...
01/10/2016 1:22 PM
Jimmy Lim woohoooo.... TP0.900
11/10/2016 4:44 PM
Noni Why ?
11/10/2016 5:05 PM
Jimmy Lim coz price keep on droping
11/10/2016 5:18 PM
smartInvestor1 downtrend.. Should drop to 1.15. Apex can't compete with other broker. Property also not good.
21/01/2017 11:54 PM
ACE9696 apex vs genting
03/04/2017 1:11 AM
ACE9696 huhuhu... bck to normal
06/04/2017 1:11 AM
Amnota Interesting counter
25/06/2017 2:14 AM
James James just now done 1.76
07/09/2017 4:45 PM
James James already up 0,34
07/09/2017 4:45 PM
ACE9696 wulamak! tiba tiba
07/09/2017 11:37 PM
ACE9696 TP 3.000
08/09/2017 10:03 AM
chrispsng KUALA LUMPUR: Apex Equity Holdings Bhd saw 23% of its paid-up traded off-market at midday on Friday at RM2 each.

Stock market data showed that 49.77 million shares were crossed at RM2 each, which was 21 sen or 11.7% above Thursday's closing price of RM1.79.

At midday, the share price of the stockbroking company was up six sen to RM1.85.

In the second quarter ended June 30, 2017, its earnings rose 54% to RM3.84mil from the RM2.49mil a year ago.

In the first half, its earnings jumped 107% to RM8.35mil from RM4.02mil in the previous corresponding period.
TAGS / KEYWORDS:
Corporate News , Markets

Read more at http://www.thestar.com.my/business/business-news/2017/09/08/apex-equity-sees-23pct-stake-traded-off-market-at-rm2-each/#rO4UckZ2KpGFfm0g.99
08/09/2017 2:57 PM
Goldchia MH China company are buying up ? To 2.80?
08/09/2017 9:23 PM
Noni LOL! Chinaman or any person willing to buy 23% at 2.00 with bigger voting rights and controlling %.
Are you willing to even pay 2.00 for a 0.1% stake with no say?
08/09/2017 9:29 PM
ACE9696 kuat
05/03/2018 11:12 PM
daren drop so heavy today?
15/03/2018 10:15 AM
apolloang what happen another limit down?
15/03/2018 10:17 AM
nyapheng rebound
15/03/2018 11:01 AM
Jimmy Lim sapu
15/03/2018 12:09 PM
Syndicates insider trading
15/03/2018 12:14 PM
Sebastian Power kena margin call kot
15/03/2018 3:53 PM
Secret Hope to move up to 1.15 tomorrow
15/03/2018 4:56 PM
BlackWhite Hi, invest stock with own money not borrowed money, since is not sure win, lots ppl died on margin
16/03/2018 9:21 AM
Syndicates why top 30 holders dont feel stress when they are having paper loss?
16/03/2018 10:27 AM
bearguy Either Azizan or Lim Siew Kin dump the shares, since ex chairman no longer in position, no more reason to stay. Fundamental still intact.
16/03/2018 10:33 AM
leroy Down below RM1
26/04/2018 4:14 PM
ACE9696 wa lao eh
27/04/2018 1:15 AM
Buylowselllower Become shareholder of company again ! ! !
21/08/2018 3:39 PM
Michaelphlee Apex said it will pay RM22mil cash to Mercury Securities three days after the deal becomes unconditional. It will issue 100 million new shares at 92 sen each to Mercury Securities and pay the remaining RM26mil in cash to complete the deal.

To raise cash for the acquisition, Apex said it plans to place out 20 million new shares at a price to be determined at a later date. Mercury Securities will end up with a 31% stake in the enlarged Apex Equity group.


Read more at https://www.thestar.com.my/business/business-news/2018/09/21/apex-equity-to-merge-with-mercury-securities/#2FpuHfOBll1kjoii.99
21/09/2018 9:13 PM
Buylowselllower Sold out all my holding share, merger with other company, issue new share, private placement share, I feel no good as a shareholder. About PE 15 is a high price for me,probably my business sense not good as BOD.
24/09/2018 11:41 AM
afterlight PE 15 for a sun-setting stockbroking business... use the money to invest banking stock like PBB and Maybank better...
26/09/2018 12:19 PM
Michaelphlee Looks like purposely suppress the price. SC should investigate.
29/09/2018 6:02 PM
leroy Limit up
03/10/2018 3:11 PM
dompeilee Hmmm...recommended to my paying subscribers when it dropped sharply in March...then decided 2 put my $ where my mouth was & bought some @ 1.0533...

Was so disappointed when they wanted to issue shares @ 92c lately...

Now....=)))
03/10/2018 4:06 PM
zhen wei & JP congratulation dompei. kaya sudah.....


@afterlight,
not all fund have such capability to absorb. 10 out of 3 only succed to retain their exisiting fund.
so far i meet few great manager like Lee.S.Y , See.Y.H . AUM /5 billion above.
last month cimb sold thier APAC<< they probably forsee going to be tough days ahead.

sunset industry to be? :(
03/10/2018 6:36 PM
Michaelphlee 13.02.2019- “the Board of Directors of the Company, AIBB wishes to announce that Apex, JF Apex and Mercury Securities had mutually agreed to extend the Due Diligence Period until 18 March 2019.” Don’t feel good.
13/02/2019 9:51 PM
Nickychung Post removed. Why?
06/11/2019 2:02 PM
YAPSS YAPSS Quick Summary of Apex Equity Holdings Berhad:
https://www.yapss.com/forum/klse-forum/apex-equity-holdings-berhad-apex-5088
06/12/2019 7:06 PM
mf https://www.theedgemarkets.com/article/apex-healthcare-may-rise-higher-says-rhb-retail-research-0
15/05/2020 8:23 AM
vatbitrage technical analysis upawing
20/05/2020 1:44 PM
gick891214 Tomorrow limit up again
22/07/2020 9:27 PM
NPRA1985 China's Sinopharm says data 'better than expected' from it's COVID vaccine trial

https://www.livemint.com/companies/news/china-s-sinopharm-says-data-better-than-expected-from-it-s-covid-vaccine-trial-11605100199684.html
13/11/2020 5:10 PM
Bamboo Green Very quiet
07/02/2021 2:15 PM
BetterTomorrow Ace credit sell to norminee to fulfil the requirements! What is the different? Still controlling the board
09/07/2021 4:41 PM
guppycrow Fpo in borneo on oct bmd.
01/09/2021 8:52 AM